GALECTIN-3 LEVELS AND OUTCOMES IN PERIPARTUM CARDIOMYOPATHY: RESULTS FROM THE MULTICENTER IPAC INVESTIGATION

Peripartum cardiomyopathy (PPCM) is a major cause of morbidity and mortality among women. The IPAC (Investigations in Pregnancy-Associated Cardiomyopathy) study is a prospective multicenter cohort study that evaluated outcomes in women with PPCM. The biomarker galectin-3 is linked to fibrosis and